These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 11185673)

  • 21. Sequential design approaches for bioequivalence studies with crossover designs.
    Potvin D; DiLiberti CE; Hauck WW; Parr AF; Schuirmann DJ; Smith RA
    Pharm Stat; 2008; 7(4):245-62. PubMed ID: 17710740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the reference scaled bioequivalence semi-replicate method with other approaches: focus on human exposure to drugs.
    Karalis V; Symillides M; Macheras P
    Eur J Pharm Sci; 2009 Aug; 38(1):55-63. PubMed ID: 19524039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How order affects the sign test.
    Rayner JC; Best DJ
    Biometrics; 1997 Dec; 53(4):1416-21. PubMed ID: 9453784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The crossover experiment for clinical trials.
    Brown BW
    Biometrics; 1980 Mar; 36(1):69-79. PubMed ID: 7370374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of two-period crossover design in a multicenter clinical trial.
    Castellana JV; Patel HI
    Biometrics; 1985 Dec; 41(4):969-77. PubMed ID: 3830261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Testing for qualitative interactions between treatment effects and patient subsets.
    Gail M; Simon R
    Biometrics; 1985 Jun; 41(2):361-72. PubMed ID: 4027319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of baseline covariates on the efficiency of statistical analyses of crossover designs.
    Yan Z
    Stat Med; 2013 Mar; 32(6):956-63. PubMed ID: 22903413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crossover trials are only useful when there is a positive correlation between the response to different treatment modalities.
    Cleophas TJ
    Br J Clin Pharmacol; 1996 Mar; 41(3):235-9. PubMed ID: 8866924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical trials: relevance of correlation between treatment responses.
    Cleophas TJ
    Eur J Clin Pharmacol; 1996; 50(1-2):1-6. PubMed ID: 8739804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A recommended analysis for 2 × 2 crossover trials with baseline measurements.
    Mehrotra DV
    Pharm Stat; 2014; 13(6):376-87. PubMed ID: 25230245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Testing equality of treatment variances in a two-by-two crossover study.
    Bristol DR
    J Biopharm Stat; 1991; 1(2):185-92. PubMed ID: 1844695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On multiperiod crossover studies.
    Fleiss JL
    Biometrics; 1986 Jun; 42(2):449-50. PubMed ID: 3741982
    [No Abstract]   [Full Text] [Related]  

  • 33. A mixed crossover and parallel group design in psychopharmacological research--example B.
    Collins BE; Henker B; Whalen C
    Psychopharmacol Bull; 1979 Jul; 15(3):40-2. PubMed ID: 493460
    [No Abstract]   [Full Text] [Related]  

  • 34. Crossover studies are a better format for comparing equivalent treatments than parallel-group studies.
    Cleophas TJ; de Vogel EM
    Pharm World Sci; 1998 Jun; 20(3):113-7. PubMed ID: 9618734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical trials in chronic diseases.
    Cleophas TJ; Tavenier P
    J Clin Pharmacol; 1995 Jun; 35(6):594-8. PubMed ID: 7665719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crossover trials with a binary response: a powerful method despite the carryover effect.
    Cleophas TJ; van Lier HJ
    J Clin Pharmacol; 1996 Mar; 36(3):198-202. PubMed ID: 8690812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The two-period crossover design in medical research.
    Woods JR; Williams JG; Tavel M
    Ann Intern Med; 1989 Apr; 110(7):560-6. PubMed ID: 2923388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A critique of recent research on the two-treatment crossover design.
    Fleiss JL
    Control Clin Trials; 1989 Sep; 10(3):237-43. PubMed ID: 2676339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Underestimation of treatment effect in crossover trials.
    Cleophas TJ
    Angiology; 1990 Sep; 41(9 Pt 1):673-80. PubMed ID: 2221469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A simple method for the estimation of interaction bias in crossover studies.
    Cleophas TJ
    J Clin Pharmacol; 1990 Nov; 30(11):1036-40. PubMed ID: 2243151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.